Showing results (281-290 of 378) with videos related to

Sort By:
Pageof 38
Diabetologia|July 1, 1994
LDL subclasses in IDDM patients: relation to diabetic nephropathyS Lahdenperä, P H Groop, M Tilly-Kiesi, et al.
Diabetes|May 20, 1998
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjectsR Malmström, C J Packard, M Caslake, et al.
The American Journal of Physiology|June 11, 1999
A marathon run increases the susceptibility of LDL to oxidation in vitro and modifies plasma antioxidantsM L Liu, R Bergholm, S Mäkimattila, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemiaE Tahvanainen, P Pajukanta, K Porkka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII)M Tilly-Kiesi, A H Lichtenstein, J M Ordovas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemiaK Ylitalo, P Pajukanta, S Meri, et al.
The Journal of Biological Chemistry|August 15, 1997
The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70E A Fisher, M Zhou, D M Mitchell, et al.
Journal of Cardiovascular Risk|December 29, 1998
Safety and efficacy of Omacor in severe hypertriglyceridemiaW S Harris, H N Ginsberg, N Arunakul, et al.
Pageof 38